Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-02-25

Clinical Trial Update: Lisdexamfetamine Dimesylate (LDX) Pilot Cognition Study to Evaluate the Utility of a Standardized Battery of Tests in Adults With Attention-Deficit Hyperactivity Disorder (ADHD) [Phase 1]

View source ↗

Summary

Phase 1 pilot cognition study assessing a standardized test battery for adults with ADHD using lisdexamfetamine dimesylate (LDX).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LISDEXAMFETAMINE DIMESYLATE (Lisdexamfetamine dimesylate)

Snippet

Sponsor: Shire | Conditions: Attention-Deficit Hyperactivity Disorder | Phase 1 | Status: COMPLETED | Results posted: 2011-02-25